- Page 2 and 3: INFORMATION NOTICE The Canadian Pan
- Page 6 and 7: Tab Annex L: Federal Emergency Prep
- Page 8 and 9: Pandemic Influenza Committee Federa
- Page 10 and 11: Quebec Dr. Yves Robert (Past Provin
- Page 12 and 13: Dr. Carole Beaudoin Manitoba Health
- Page 14 and 15: Ms. Rolande D’Amour Public Health
- Page 16: PREFACE
- Page 19 and 20: For this edition, the Plan has been
- Page 22 and 23: Table of Contents 1.0 Goals and Obj
- Page 24 and 25: Introduction 1.0 Goals and Objectiv
- Page 26 and 27: The content of this comprehensive p
- Page 28: Section Two BACKGROUND
- Page 31 and 32: ii The Canadian Pandemic Influenza
- Page 33 and 34: Direct transmission of avian H5N1 i
- Page 35 and 36: 2.3 Impact The impact of the pande
- Page 37 and 38: Table1 : Daily Peak All-Cause Absen
- Page 39 and 40: Based on the 1999 analysis using th
- Page 41 and 42: 4.1.1 Interpandemic Period Phase De
- Page 43 and 44: Phase Definition Example(s) 5.1 Sin
- Page 45 and 46: In accordance with the IHRs, there
- Page 47 and 48: In summary, the principles of publi
- Page 50 and 51: Table of Contents 1.0 Introduction
- Page 52 and 53: Preparedness 1.0 Introduction 1.1 B
- Page 54 and 55:
Each of the Plan components in this
- Page 56 and 57:
continue to function. Special study
- Page 58 and 59:
Ministère de la Santé et des Serv
- Page 60 and 61:
focus on delivering a two-dose prog
- Page 62 and 63:
agreed that the national stockpile
- Page 64 and 65:
2.4.1 Current Status Outbreaks of i
- Page 66 and 67:
ii) iii) Clinical management of inf
- Page 68 and 69:
2.5 Public Health Measures Certain
- Page 70 and 71:
consistent and coherent messaging a
- Page 72 and 73:
5) The PIC communications subcommit
- Page 75 and 76:
Table of Contents 1.0 Introduction
- Page 77 and 78:
Response 1.0 Introduction In this R
- Page 79 and 80:
The SARS experience reinforced the
- Page 81 and 82:
6.1 Interpandemic Period Canadian P
- Page 83 and 84:
Canadian Phase 2.0 No new virus sub
- Page 85 and 86:
Canadian Phase 3.0 Human infection(
- Page 87 and 88:
Canadian Phase 3.1 Sporadic human i
- Page 89 and 90:
Canadian Phases 4.0 and 5.0 Cluster
- Page 91 and 92:
Canadian Phases 4.0 and 5.0 Cluster
- Page 93 and 94:
Canadian Phases 4.1 and 5.1 Sporadi
- Page 95 and 96:
Canadian Phases 4.2 and 5.2 Localiz
- Page 97 and 98:
Canadian Phases 4.2 and 5.2 Localiz
- Page 99 and 100:
Canadian Phase 6.0 Outside Canada,
- Page 101 and 102:
Canadian Phases 6.1 and 6.2 Pandemi
- Page 103 and 104:
Canadian Phases 6.1 and 6.2 Pandemi
- Page 105 and 106:
6.4 Post-Pandemic Period The follow
- Page 107 and 108:
Component Focus Actions Response Le
- Page 110 and 111:
Table of Contents Annexes: Tab A: P
- Page 113 and 114:
A Planning Checklists Table of Cont
- Page 115 and 116:
1.0 Introduction Planning for a pan
- Page 117 and 118:
Verify the capacity of suppliers fo
- Page 119 and 120:
1.5 Public Health Measures Checklis
- Page 121:
Annex B Pandemic Influenza Planning
- Page 124 and 125:
Provision of public health services
- Page 126 and 127:
Table 1: The Key Activities and Pro
- Page 128 and 129:
3. FNIHB Headquarters 3.1 Develop a
- Page 130:
Annex C Pandemic Influenza Laborato
- Page 133 and 134:
Appendices A. Nasopharyngeal Swab P
- Page 135 and 136:
ecommendations on the use of rapid
- Page 137 and 138:
secretariat. An up-to-date list wil
- Page 139 and 140:
Phase 3.1 The PHLs and other viral
- Page 141 and 142:
Additional supplies of appropriate
- Page 143 and 144:
Agreements will need to be establis
- Page 145 and 146:
Appendix A: Nasopharyngeal Swab Pro
- Page 147 and 148:
Appendix B: Members of the Pandemic
- Page 149 and 150:
Appendix C: List of Acronyms Organi
- Page 151 and 152:
2 The Canadian Pandemic Influenza P
- Page 153 and 154:
ii The Canadian Pandemic Influenza
- Page 155 and 156:
3. Recommended Priority Groups for
- Page 157 and 158:
Group 5: Children, 24 Months to 18
- Page 160 and 161:
E Planning Recommendations for the
- Page 162 and 163:
1.0 Introduction The purpose of thi
- Page 164 and 165:
Antiviral (Anti-Influenza) Drugs Cu
- Page 166 and 167:
At a joint meeting of the Council o
- Page 168 and 169:
Containment The role and impact of
- Page 170 and 171:
6.0 Outstanding Issues There are a
- Page 172:
Annex F Infection Control and Occup
- Page 175 and 176:
Executive Summary The Infection Con
- Page 177 and 178:
Interim Infection Control Guideline
- Page 179 and 180:
Decontaminate hands Decontamination
- Page 181 and 182:
Non traditional health care setting
- Page 183 and 184:
Part B: Pandemic Influenza in Tradi
- Page 185 and 186:
Part A. Overview of Pandemic Influe
- Page 187 and 188:
2.3 Airborne Transmission Refers to
- Page 189 and 190:
Discard them into an appropriate re
- Page 191 and 192:
3.1.1 Recommendations 1. All organi
- Page 193 and 194:
3.2.4 Immunity to Influenza During
- Page 195 and 196:
4.0 Pandemic Influenza Education 4.
- Page 197 and 198:
(b) information regarding Self Care
- Page 199 and 200:
It is thought that management of ex
- Page 201 and 202:
C. Infection Control Practices 1. R
- Page 203 and 204:
(e) Sterilization in Health Care 3
- Page 205 and 206:
3. Visitors should be informed when
- Page 207 and 208:
(d) 3. Masks and eye protection, or
- Page 209 and 210:
F. Cohorting 1. Cohorting resident
- Page 211 and 212:
B. Physical Setting 1. If possible,
- Page 213 and 214:
iii. Gowns 1. Gowns are not require
- Page 215 and 216:
(c) Personal Protective Equipment i
- Page 217 and 218:
Recommendations A. Pandemic Plannin
- Page 219 and 220:
(d) (e) membranes to reduce the pot
- Page 221 and 222:
All patients’ blood and body secr
- Page 223 and 224:
(c) Masks 1. Wearing masks, when fa
- Page 225 and 226:
ii. Do not send students who have b
- Page 227 and 228:
Control of Pandemic Influenza A. Im
- Page 229 and 230:
Masks 1. Wearing masks when face-to
- Page 231 and 232:
2. When planning for the location o
- Page 233 and 234:
3. Personal Protective Equipment a.
- Page 235 and 236:
iv. Reuse of single use items is st
- Page 237 and 238:
2.0 Infection Prevention and Contro
- Page 239 and 240:
iii. Individuals should avoid touch
- Page 241 and 242:
4. Care of the Deceased Attention t
- Page 243 and 244:
. Hands should be washed or hand an
- Page 245 and 246:
. Gloves i. Gloves are not required
- Page 247 and 248:
Recommendations 1. Process a. Repro
- Page 249 and 250:
G. Environmental Control (Housekeep
- Page 251 and 252:
always removed before leaving the l
- Page 253 and 254:
iii. Separate carts should be used
- Page 255 and 256:
immediately in designated puncture-
- Page 257 and 258:
Appendix II. World Health Organizat
- Page 259 and 260:
Appendix III. Hand Hygiene Procedur
- Page 261 and 262:
Appendix IV. An Influenza-like Illn
- Page 263 and 264:
Table B. Directions for Preparing a
- Page 265 and 266:
16. Garner JS, HICPAC. Guideline fo
- Page 267 and 268:
50. Smith PW, Rusnak PG. Infection
- Page 269 and 270:
83. Drinka PJ, Krause P, Schilling
- Page 271 and 272:
117. Alfa MJ, Olson N, DeGagne P, H
- Page 273 and 274:
148. Reinhardt PA, Gordon JG, Alvar
- Page 276 and 277:
G Health Services: Clinical Care Gu
- Page 278 and 279:
Chapter 3. Patient Management II: M
- Page 280 and 281:
Chapter 1. Clinical Presentations o
- Page 282 and 283:
The severity of clinical disease du
- Page 284 and 285:
Chlamydia pneumoniae and Mycoplasma
- Page 286 and 287:
People of any age who are residents
- Page 288 and 289:
Although pre-existing cardiovascula
- Page 290 and 291:
predominantly mononuclear, and capi
- Page 292 and 293:
1.2.5 Muscular system Acute rhabdom
- Page 294 and 295:
Table 1.3. Comparative features of
- Page 296 and 297:
Triage of adults ( 18 years) 1 Tria
- Page 298 and 299:
Symptoms consistent with flu like i
- Page 300 and 301:
Secondary influenza illness assessm
- Page 302 and 303:
Co-morbidity: in addition to above
- Page 304 and 305:
Child with acute respiratory illnes
- Page 306 and 307:
Stiff neck, photophobia When these
- Page 308 and 309:
c) Values of WBC for young children
- Page 310 and 311:
Children at risk for influenza-asso
- Page 312 and 313:
What are the Symptoms of Influenza
- Page 314 and 315:
What Reactions do People have to th
- Page 316 and 317:
II. If You Are Unwell A. Is It The
- Page 318 and 319:
C. When To Seek Medical Attention I
- Page 320 and 321:
TAKE YOUR CHILD TO THE HOSPITAL EME
- Page 322 and 323:
Clean the thermometer with cool soa
- Page 324 and 325:
Make sure that you/the person whose
- Page 326 and 327:
What you can do for yourself (uncom
- Page 328 and 329:
If your child has symptoms/behavior
- Page 330 and 331:
What You Can Do For Your Child All
- Page 332 and 333:
Details of vaccination Yes No N/A B
- Page 334 and 335:
Provisional Diagnosis Please Tick A
- Page 336 and 337:
Details of vaccination Yes No N/A B
- Page 338 and 339:
Examination Findings (children 18 y
- Page 340 and 341:
Investigations in Adults ( 18 years
- Page 342 and 343:
If not admitted: Sent to: Home car
- Page 344 and 345:
Provisional Diagnosis Please Tick a
- Page 346 and 347:
Appendix 2.III. Pulse Oximetry and
- Page 348 and 349:
Normal values (Fig. 2.1) Normal val
- Page 350 and 351:
Chapter 3. Patient Management II Ma
- Page 352 and 353:
3.2.2 Diagnosis and management of r
- Page 354 and 355:
cultures should be considered in in
- Page 356 and 357:
3.3 Timely diagnosis and management
- Page 358 and 359:
Chapter 4. Patient Management III M
- Page 360 and 361:
5.3 Ward management Standard ward m
- Page 362 and 363:
5.4 Intensive Care Unit (ICU) Manag
- Page 364 and 365:
Details of vaccination Yes No N/A B
- Page 366 and 367:
Examination Findings Date _____/___
- Page 368 and 369:
Other investigations Investigation
- Page 370 and 371:
Disposition Admitted ICU General
- Page 372 and 373:
Procedure Table 5.1. Diagnostic tes
- Page 374 and 375:
Appendix 5.IV. Antibiotics Antimicr
- Page 376 and 377:
Table 5.6. Suggested empiric antimi
- Page 378 and 379:
Table 5.8. Suggested empiric antimi
- Page 380 and 381:
First Nations’ communities in the
- Page 382 and 383:
6.1.2 Triage of patients in small c
- Page 384 and 385:
6.1.3 Initial assessment The initia
- Page 386 and 387:
6.1.6 Discharge Criteria Once the p
- Page 388 and 389:
6.2.3 Triage of patients in correct
- Page 390 and 391:
6.2.3.2. Secondary assessment (Chap
- Page 392 and 393:
References 1. ACIP April 20, 2001,
- Page 394 and 395:
32. CDC. 2002. Update: Influenza ac
- Page 396 and 397:
67. FluWatch 2001, posting date. De
- Page 398 and 399:
102. Horman JT, Stetler HC, Israel
- Page 400 and 401:
136. Loukides S, and Polyzogopoulos
- Page 402 and 403:
167. Nolte KB, Alakija P, Oty G, Sh
- Page 404 and 405:
200. Spillet D. 2001. Caring for yo
- Page 406 and 407:
233. Wright PF, Thompson J, McKee K
- Page 409 and 410:
H Resource Management Guidelines Fo
- Page 411 and 412:
Introduction During influenza epide
- Page 413 and 414:
f) A pandemic vaccine may be unavai
- Page 415 and 416:
2.1.2 Identify Triggers for Impleme
- Page 417 and 418:
availability of resources, stage of
- Page 419 and 420:
cohorting infectious and non-infect
- Page 421 and 422:
demands on the health care faciliti
- Page 423 and 424:
insurance, both site insurance, wor
- Page 425 and 426:
3.2.4 Consider Insurance and Licens
- Page 427 and 428:
3.3 Human Resource Management Durin
- Page 429 and 430:
3.3.6 Support Health Care Workers R
- Page 431 and 432:
3. What is the total number of vent
- Page 433 and 434:
Types of ventilators Intensive care
- Page 435 and 436:
Appendix B: Example Supply Manageme
- Page 438 and 439:
I Guidelines for the Management of
- Page 440 and 441:
Introduction During a pandemic, loc
- Page 442 and 443:
Steps Requirements Limiting Factors
- Page 444 and 445:
Any changes to regular practices pe
- Page 446 and 447:
Visitations could be a concern in t
- Page 448 and 449:
Appendix 1: List of Current Supplie
- Page 451 and 452:
J Guidelines for Non-Traditional Si
- Page 453 and 454:
Introduction In influenza pandemics
- Page 455 and 456:
1.3 Administrative Options for Non-
- Page 457 and 458:
obtain an Emergency Hospital or oth
- Page 459 and 460:
Designation of NT sites as triage c
- Page 461 and 462:
space for reception, waiting, patie
- Page 463 and 464:
Transportation and Supply Logistics
- Page 465 and 466:
1.7.2 Appoint Site Administrators/M
- Page 467 and 468:
Section 2: Human Resources Issues 2
- Page 469 and 470:
Health Care Workers (HCWs) Within f
- Page 471 and 472:
FUNCTIONS SKILL SETS/PERSONNEL B Pa
- Page 473 and 474:
safety and protection of workers, (
- Page 475 and 476:
a. Communicate with volunteer agenc
- Page 477 and 478:
ii) iii) iv) training programs will
- Page 479 and 480:
2.2.8 Establish Immunization Recomm
- Page 481 and 482:
2.3 Human Resource Planning During
- Page 483 and 484:
Due Diligence: The volunteer recrui
- Page 485 and 486:
K Canadian Pandemic Influenza Plan
- Page 487 and 488:
Primary Communications Roles Primar
- Page 489 and 490:
Primary Communications Roles Primar
- Page 491 and 492:
Primary Communications Roles Primar
- Page 493 and 494:
Primary Communications Roles Primar
- Page 495 and 496:
Provinces/Territories Primary Commu
- Page 497 and 498:
Pandemic Phase - National Communica
- Page 499 and 500:
Provinces/Territories Primary Commu
- Page 501:
Annex L Federal Emergency Preparedn
- Page 504 and 505:
ii The Canadian Pandemic Influenza
- Page 506 and 507:
The National Security Policy recogn
- Page 508 and 509:
National Emergency Response System
- Page 510 and 511:
3. The Centre for Emergency Prepare
- Page 512 and 513:
Public Health Agency of Canada and
- Page 514:
Annex M Public Health Measures Date
- Page 517 and 518:
7.0 Community Based Disease Control
- Page 519 and 520:
2.0 Principles and Assumptions The
- Page 521 and 522:
Review and update educational mater
- Page 523 and 524:
4.0 Avian Outbreaks in Canada durin
- Page 525 and 526:
Medical management of these individ
- Page 527 and 528:
which they are expected to be commu
- Page 529 and 530:
Scrupulous hand and respiratory hyg
- Page 531 and 532:
6.0 Management of Contacts of Cases
- Page 533 and 534:
Activity Restriction Antiviral Use
- Page 535 and 536:
Antiviral Use Consider the use of
- Page 537 and 538:
6.3 Rationale If outbreaks occur in
- Page 539 and 540:
7.0 Community-Based Disease Control
- Page 541 and 542:
7.2 Close Schools and Daycare Centr
- Page 543 and 544:
7.4 Use of masks by well individual
- Page 545 and 546:
7.6 Increase frequency of cleaning
- Page 547 and 548:
9.0 Travel and Border-Related Measu
- Page 549 and 550:
International Origin: Canadian Pand
- Page 551 and 552:
Domestic Origin: Canadian Pandemic
- Page 553 and 554:
Pandemic Period: Canadian Pandemic
- Page 555 and 556:
Appendix A: Summary of Recommendati
- Page 557:
Annex N Pandemic Influenza Surveill
- Page 560 and 561:
Preamble Since 2004, Canadian publi
- Page 562 and 563:
detection and characterization of u
- Page 564 and 565:
Interpandemic Period Table 1: Inter
- Page 566 and 567:
Table 1.1: National Surveillance Da
- Page 568 and 569:
Table 2: Pandemic Alert Period Cana
- Page 570 and 571:
Canadian Pandemic Phase 4.0 Outside
- Page 572 and 573:
Surveillance Objectives/Roles and R
- Page 574 and 575:
Table 2.1: National Surveillance Da
- Page 576 and 577:
Canadian Pandemic Phase 4.0 Outside
- Page 578 and 579:
Pandemic Period Table 3: Pandemic P
- Page 580 and 581:
Table 3.1: National Surveillance Da
- Page 582 and 583:
Canadian Pandemic Phase 6.2 Localiz
- Page 584 and 585:
Appendix 1: Generic Serosurvey Prot
- Page 586 and 587:
Laboratory methods As the antibody
- Page 588 and 589:
Annex 1 Sample Questionnaire for Av
- Page 590 and 591:
During the exposure period (to defi
- Page 592 and 593:
If exposed to infected poultry Plea
- Page 594 and 595:
If “yes” indicate what type of
- Page 596 and 597:
Appendix 3: National SRI Investigat
- Page 599 and 600:
Glossary of Terms and List of Acron
- Page 601 and 602:
Epidemiology Flu F/P/T Goblet cell
- Page 603 and 604:
Interpandemic Period Isolate Isolat
- Page 605 and 606:
NPS Neuraminidase (N) Neuraminidase
- Page 607 and 608:
Preventive care Preventive medicine
- Page 609 and 610:
Standard deviation (statistical) St